David G. Longfellow

IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene

Ahti Anttila, Ramesh V. Bhat, James A. Bond et al. · 2002 · 773 citations

Chemoprevention Strategy, Pathology, Toxicology Testing +25

Arsenic: health effects, mechanisms of actions, and research issues.

Charles O. Abernathy, Y P Liu, David G. Longfellow et al. · Environmental Health Perspectives · 1999 · 628 citations · Full text

Redox Biology, Toxicological Mechanism, Oxidative Stress +19

Pathology related to chronic arsenic exposure.

José A. Centeno, Florabel G. Mullick, Leonor Martinez et al. · Environmental Health Perspectives · 2002 · 306 citations · Full text

Pathology, Environmental Arsenic Exposure, Dermatology +18

Strategy and planning for chemopreventive drug development: Clinical development plans II

Gary J. Kelloff, James A. Crowell, Ernest T. Hawk et al. · Journal of Cellular Biochemistry · 1996 · 191 citations

Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide

Mario Altamirano‐Lozano, Detmar Beyersmann, Dean E. Carter et al. · Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) · 2006 · 191 citations